Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 490

1.

Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.

Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS; Canadian Hypertension Education Program.

Can J Cardiol. 2014 Jan;30(1):16-21. doi: 10.1016/j.cjca.2013.07.008. Epub 2013 Oct 23. Review.

PMID:
24269056
2.

Renal denervation in moderate treatment-resistant hypertension.

Ott C, Mahfoud F, Schmid A, Ditting T, Sobotka PA, Veelken R, Spies A, Ukena C, Laufs U, Uder M, Böhm M, Schmieder RE.

J Am Coll Cardiol. 2013 Nov 12;62(20):1880-6. doi: 10.1016/j.jacc.2013.06.023. Epub 2013 Jul 10.

3.

Catheter-based renal denervation for drug-resistant hypertension by using a standard electrophysiology catheter.

Prochnau D, Lucas N, Kuehnert H, Figulla HR, Surber R.

EuroIntervention. 2012 Jan;7(9):1077-80. doi: 10.4244/EIJV7I9A171.

4.

Percutaneous renal sympathetic denervation: 2013 and beyond.

Froeschl M, Hadziomerovic A, Ruzicka M.

Can J Cardiol. 2014 Jan;30(1):64-74. doi: 10.1016/j.cjca.2013.11.003. Epub 2013 Nov 7. Review.

PMID:
24365191
5.

Catheter-based renal denervation for resistant hypertension: 12-month results of the EnligHTN I first-in-human study using a multielectrode ablation system.

Papademetriou V, Tsioufis CP, Sinhal A, Chew DP, Meredith IT, Malaiapan Y, Worthley MI, Worthley SG.

Hypertension. 2014 Sep;64(3):565-72. doi: 10.1161/HYPERTENSIONAHA.114.03605. Epub 2014 Jun 16.

PMID:
24935940
6.

Efficacy and safety of renal denervation in elderly patients with resistant hypertension.

Ziegler AK, Bertog S, Kaltenbach B, Id D, Franke J, Hofmann I, Vaskelyte L, Sievert H.

Catheter Cardiovasc Interv. 2015 Aug;86(2):299-303. doi: 10.1002/ccd.25166.

PMID:
23983010
7.

First report of the Global SYMPLICITY Registry on the effect of renal artery denervation in patients with uncontrolled hypertension.

Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G; GSR Investigators.

Hypertension. 2015 Apr;65(4):766-74. doi: 10.1161/HYPERTENSIONAHA.114.05010. Epub 2015 Feb 17.

PMID:
25691618
8.

Catheter-based renal denervation for treatment of resistant hypertension.

Vase H, Mathiassen ON, Kaltoft A, Pedersen EB, Christensen KL, Buus NH, Lederballe O, Lassen JF, Bøtker HE, Thuesen L.

Dan Med J. 2012 Jun;59(6):A4439.

PMID:
22677237
9.

[Renal denervation a treatment for resistant hypertension: a French experience].

Benamer H, Mylotte D, Garcia-Alonso C, Unterseeh T, Garot P, Louvard Y, Lefevre T, Morice MC; ICV-GVM la Roseraie.

Ann Cardiol Angeiol (Paris). 2013 Dec;62(6):384-91. doi: 10.1016/j.ancard.2013.09.003. Epub 2013 Oct 12. French.

PMID:
24182849
10.

Renal denervation with a percutaneous bipolar radiofrequency balloon catheter in patients with resistant hypertension: 6-month results from the REDUCE-HTN clinical study.

Sievert H, Schofer J, Ormiston J, Hoppe UC, Meredith IT, Walters DL, Azizi M, Diaz-Cartelle J, Cohen-Mazor M.

EuroIntervention. 2015 Feb;10(10):1213-20. doi: 10.4244/EIJY14M12_01.

11.

Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.

Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M.

Lancet. 2009 Apr 11;373(9671):1275-81. doi: 10.1016/S0140-6736(09)60566-3. Epub 2009 Mar 28.

PMID:
19332353
12.

Impact of renal denervation on 24-hour ambulatory blood pressure: results from SYMPLICITY HTN-3.

Bakris GL, Townsend RR, Liu M, Cohen SA, D'Agostino R, Flack JM, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators.

J Am Coll Cardiol. 2014 Sep 16;64(11):1071-8. doi: 10.1016/j.jacc.2014.05.012. Epub 2014 May 20.

13.

Renal sympathetic denervation as second-line therapy in mild resistant hypertension: a pilot study.

Kaltenbach B, Franke J, Bertog SC, Steinberg DH, Hofmann I, Sievert H.

Catheter Cardiovasc Interv. 2013 Feb;81(2):335-9. doi: 10.1002/ccd.24557. Epub 2012 Aug 13.

PMID:
22807098
14.

[Expert consensus statement on interventional renal sympathetic denervation for hypertension treatment].

Mahfoud F, Vonend O, Bruck H, Clasen W, Eckert S, Frye B, Haller H, Hausberg M, Hoppe UC, Hoyer J, Hahn K, Keller T, Krämer BK, Kreutz R, Potthoff SA, Reinecke H, Schmieder R, Schwenger V, Kintscher U, Böhm M, Rump LC; Arbeitsgemeinschaft Herz und Niere der Deutschen Gesellschaftfür Kardiologie – Herz- und Kreislaufforschunge V und der Deutschen Gesellschaft für Nephrologiee  V sowie der Deutschen Hochdruckliga e V DHL® – DeutscheGesellschaft für Hypertonie und Prävention.

Dtsch Med Wochenschr. 2011 Nov;136(47):2418. doi: 10.1055/s-0031-1272580. Epub 2011 Nov 2. German.

PMID:
22048949
15.

Blood Pressure Response to Main Renal Artery and Combined Main Renal Artery Plus Branch Renal Denervation in Patients With Resistant Hypertension.

Fengler K, Ewen S, Höllriegel R, Rommel KP, Kulenthiran S, Lauder L, Cremers B, Schuler G, Linke A, Böhm M, Mahfoud F, Lurz P.

J Am Heart Assoc. 2017 Aug 10;6(8). pii: e006196. doi: 10.1161/JAHA.117.006196.

16.

Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial.

Kandzari DE, Bhatt DL, Sobotka PA, O'Neill WW, Esler M, Flack JM, Katzen BT, Leon MB, Massaro JM, Negoita M, Oparil S, Rocha-Singh K, Straley C, Townsend RR, Bakris G.

Clin Cardiol. 2012 Sep;35(9):528-35. doi: 10.1002/clc.22008. Epub 2012 May 9.

17.
18.

Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy?

Armaganijan L, Staico R, Moraes A, Abizaid A, Moreira D, Amodeo C, Sousa M, Borelli F, Armaganijan D, Sousa JE, Sousa A.

Arq Bras Cardiol. 2014 Apr;102(4):355-63. doi: 10.5935/abc.20140034. Epub 2014 Feb 17. English, Portuguese.

19.

12-month blood pressure results of catheter-based renal artery denervation for resistant hypertension: the SYMPLICITY HTN-3 trial.

Bakris GL, Townsend RR, Flack JM, Brar S, Cohen SA, D'Agostino R, Kandzari DE, Katzen BT, Leon MB, Mauri L, Negoita M, O'Neill WW, Oparil S, Rocha-Singh K, Bhatt DL; SYMPLICITY HTN-3 Investigators.

J Am Coll Cardiol. 2015 Apr 7;65(13):1314-1321. doi: 10.1016/j.jacc.2015.01.037.

20.

Ambulatory blood pressure changes after renal sympathetic denervation in patients with resistant hypertension.

Mahfoud F, Ukena C, Schmieder RE, Cremers B, Rump LC, Vonend O, Weil J, Schmidt M, Hoppe UC, Zeller T, Bauer A, Ott C, Blessing E, Sobotka PA, Krum H, Schlaich M, Esler M, Böhm M.

Circulation. 2013 Jul 9;128(2):132-40. doi: 10.1161/CIRCULATIONAHA.112.000949. Epub 2013 Jun 18. Erratum in: Circulation. 2014 May 20;129(20):e502.

PMID:
23780578

Supplemental Content

Support Center